RICHTER LACES FINGERS TIGHTER WITH FOREST

A A

Hungary's leading drugs producer Richter Gedeon and Forest Laboratories have entered into two new collaborations for CNS (central nervous system) compounds. These two new agreements build upon the existing collaboration announced in 2004 for a novel antipsychotic. The first new collaboration will focus upon a group of compounds that target the NMDA 2B receptor and will be developed for the treatment of chronic pain and other CNS conditions.

Portfolio.hu (http://www.portfolio.hu/en/cikkek.tdp?cCheck=1&k=1&i=6443)